Monographie - Sufentanil citrate

Son güncelleme :
19/11/2024

Sufentanil citrate

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Fentatienil	İtalya
Sudolfen	Kolombiya
Sufenta	Almanya, Amerika Birleşik Devletleri, Avusturya, Belçika, Danimarka, Finlandiya, Fransa, Güney Afrika Cumhuriyeti, Hollanda, İran, İsveç, İsviçre, İzlanda, Kanada, Lüksemburg, Malezya, Norveç, Polonya, Portekiz, Şili, Suudi Arabistan, Tunus, Türkiye
Zuftil	Meksika

Kaynaklar : Sufentanil citrate

	tip	yayın
59	Dergi	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
299	Dergi	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300	Dergi	Trissel LA, Gilbert DL, Martinez JF. Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
319	Dergi	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
509	Dergi	Roos PJ, Glerum JH, Meilink JW, Zwang L. Effect of pH absorption of sufentanil citrate in a portable pump reservoir during storage and administration under simulated epidural conditions. Pharm World Sci 1993 ; 15: 139-144.
510	Dergi	Roos PJ, Glerum JH, Schroeders MJH. Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter. Pharm World Sci 1993 ; 15: 269-275.
675	Dergi	Roos PJ, Glerum JH, Meilink JW. Stability of sufentanil citrate in a portable pump reservoir, a glass container and a polyethylene container. Pharm Weekbl [Sci] 1992 ; 14: 196-200.
921	Dergi	Trissel LA, Gilbert DL, Martinez JF. Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Hosp Pharm 1998 ; 33: 284-292.
1491	Dergi	Brouwers JRBJ, van Doorne H, Meevis RF, Boersma FP. Stability of sufentanil citrate and sufentanil citrate/bupivacaine mixture in portable infusion pump reservoirs. Eur Hosp Pharm 1995 ; 1: 12-14.
1508	Dergi	Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F. Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU. EJHP 2015 ;22:123-124.
1516	Laboratuar	Ropivacaine (Naropeine®) - Summary of Product Characteristics Mercury Pharmaceuticals Limited 2012
1625	Dergi	Trissel LA, Saenz C, Williams YW, Ingram D. Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Int J Pharm Compound 2001 ; 5: 314-321.
1665	Dergi	Öster Svedberg K, McKenzie J, Larrivee-Elkins C. Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine. J Clin Pharm Ther 2002 ; 21: 39-45.
1712	Dergi	Trissel LA, Saenz CA. Compatibility screening of Precedex during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 230-233.
1713	Dergi	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	Dergi	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1752	Dergi	Jäppinen AL, Hokki H, Rasi AS, Naaranlathi TJ. Stability of sufentanil in a syringe pump under simulated epidural infusion. Int J Pharm Compound 1998 ; 2: 466-468.
1759	Dergi	Servais H, Tulkens PM. Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Antimicrob Agents Chemother 2001 ; 45: 2643-2647.
1803	Dergi	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
1835	Dergi	Jäppinen A, Turpeinen M, Kokki H, ,Rasi A, Ojanen T, Pelkonen O, Naaranlahti T. Stability of sufentanil and levobupivacain solutions and a mixture in a 0.9% sodium chloride infusion stored in polypropylene syringes. Eur J Pharm Sci 2003 ; 19, 1: 31-36.
1882	Dergi	Bosch EH, Van Doorne H, Brouwers JRBJ, Marskamp A, Meevis RF. Decrease of sufentanil citrate concentration during formulation and application of an epidural infusion solution. Ziekenhuisfarmacie 1993 ; 9: 97-101.
1908	Dergi	Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L. Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°C. J Pain Symptom Manage 2004 ; 28, 1: 4-6.
1909	Dergi	Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A. Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche. J Pharm Clin 2000 ; 19: 248-251.
1925	Dergi	Trissel LA , Williams KY, Gilbert DL. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. J Am Pharm Assoc 2000 ; 40: 515-519.
1938	Dergi	Boitquin LP, Hecq JD, Vanbeckbergen DF, Jamart J, Galanti LM. Stability of sufentanil citrate with levobupivacaine hydrochloride in NaCl 0.9% after microwave freeze-thaw treatment. Ann Pharmacotherapy 2004 ; 38: 1836-1839.
1962	Dergi	Hecq JD, Boitquin L, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L. Long term stability of sufentanyl citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion P.V.C bags at 4°C. Pharmakon 2004 ; 36, 1: 8-14.
2118	Dergi	Chapalain-Pargade S, Laville I, Paci A, Chachaty E, Mercier L, Bourget Ph. Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery-systems. J Pain Symptom Manage 2006 ; 32, 1: 90-97.
2119	Dergi	Westphal M, Hohage H, Buerckle H, Van Aken H, Ermert T, Brodner G. Adsorption of sufentanil to epidural filters and catheters. Eur J Anaesthesiol 2003 ; 20: 124-126.
2138	Dergi	Brodner G, Ermert T, Van Aken H et al. Stability of a sufentanil-ropivacaine mixture in a glass and a PVC reservoir. Eur J Anaesthesiol 2002 ; 19: 295-297.
2141	Dergi	Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM. Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. J Antimicrob Chemother 2003 ; 51: 651-658.
2146	Dergi	Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2196	Dergi	Trissel LA, Trusley C, Ben M, Kupiec TC. Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during Y-site administration. Am J Health-Syst Pharm 2007 ; 64, 11: 1209-1213.
2231	Dergi	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2280	Dergi	Shields DE, Aclan J, Szatkowski A. Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration. Int J Pharm Compound 2008 ; 12, 5: 463-466.
2319	Dergi	Janssen K, Wisselo R, Geerlings C, Schouten J.P. Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump. EJHP Science 2009 ; 15, 1: 11-14.
3012	Dergi	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3294	Dergi	Humbert-Delaloye V, Berger M, Voirol P, Pannatier A. In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs EJHP 2012 ; 19: 57-64.
3380	Dergi	Eckle V-S, Heim E, Hahn M, Grasshoff C. Incompatibility of Piritramide with Cephalosporins. Ann Pharmacotherapy 2013 ;47:426-427.
3385	Dergi	Raverdi V, Ampe E, Hecq JD, Tulkens PM. Stability and compatibility of vancomycin for administration by continuous infusion. J Antimicrob Chemother 2013 ; 68: 1179-1182.
3408	Dergi	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3504	Laboratuar	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012
3601	Laboratuar	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
3644	Laboratuar	Calcium gluconate® - Summary of Product Characteristics Hameln Pharmaceuticals 2010
3705	Dergi	Knudsen L, Eisend S, Haake N, Kunze T. Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine. EJHP 2014 ;21:161-166
3824	Dergi	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3964	Dergi	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4011	Dergi	Gersonde F, Eisend S, Haake N, Kunze T. Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit. EJHP 2016 2016;0:1-11
4080	Dergi	Zbytovska J, Gallusova J, Vidlarova L, Prochazkova K, Simek J, Stepanek F. Physical Compatibility of Propofol-Sufentanil Mixtures. Anaesthesia 2017 ;124,3:776-781
4162	Dergi	Sorrieul J, Robert J, Gibory V, Kieffer H, Folliard C, Dupoiron D, Devys C. Stability of sufentanil and baclofen mixtures for intrathecal analgesia at different concentrations in polypropylene syringes. Ann Pharm Fr 2018 ;76,6:444-452
4319	Dergi	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	Dergi	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4496	Dergi	Sorrieul J, Robert J, Dupoiron D, Devys, C. Stability Study of Admixtures Combining Ziconotide With Morphine or Sufentanil in Polypropylene Syringes. Neuromodulation 2020 ; 24, 7: 1145-1156.
4522	Dergi	Lin Q, Van Schepdael A, Adams E. Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV. J Pharm Biomed Anal 2020
4742	Dergi	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.

Mentions Légales